EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing the Impact of Bedaquiline, Clofazimine, and Linezolid on Mycobacterial Genome Integrity

Dániel Molnár iD, Éva Viola Surányi iD, Nikoletta Gálik, Judit Tóth iD, Rita Hirmondó iD

Biomolecules · 2024

DOI: 10.3390/biom14111451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Dániel Molnár und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, 1117 Budapest, Hungary. Hauptthemen laut MEDLINE: Clofazimine, Diarylquinolines, Linezolid, Antitubercular Agents. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Office for Research and Technology, Hungary.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB) presents significant medical challenges, largely due to the genetic diversity of Mycobacterium tuberculosis, which enhances the resilience and resistance of the pathogen to first-line treatments. In response to the global rise of drug-resistant TB, second-line antitubercular drugs like bedaquiline (BDQ), linezolid (LZD), and clofazimine (CFZ) have become critical treatment options. Understanding the molecular changes these drugs induce is essential for optimizing TB therapy. To contribute to this effort, we investigated their impact on genome maintenance and stability using Mycobacterium smegmatis as a model organism. Using mutation accumulation assays and whole-genome sequencing, we found that the second-line antibiotics did not significantly increase mutation rates, unlike the positive control UV treatment. However, upon BDQ treatment, we detected mutations in transporter proteins and transcription factors without any increase in the minimal inhibitory concentration. Additionally, BDQ and CFZ were found to alter DNA repair pathways and reduce cellular dNTP levels, particularly CFZ, which depleted dGTP, impacting DNA synthesis. CFZ also upregulated DNA repair enzymes, enhancing error-free repairs. Despite minimal mutagenic effects, both drugs displayed distinct impacts on cellular mechanisms, suggesting additional modes of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClofazimineDiarylquinolinesLinezolidAntitubercular AgentsGenome, BacterialMicrobial Sensitivity TestsMycobacterium smegmatisMycobacterium tuberculosisMutationGenomic InstabilityDNA Repair

Stichwörter der Autor:innen

DNA repairdrug resistancegenome integritymycobacteriasecond-line antituberculotics

Substanzen

bedaquilineClofazimineDiarylquinolinesLinezolidAntitubercular Agents

Autor:innen und Institutionen

  • Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, 1117 Budapest, Hungary.
  • Doctoral School of Biology and Institute of Biology, ELTE Eötvös Loránd University, 1117 Budapest, Hungary.

ORCID-Profile: Dániel Molnár, Éva Viola Surányi, Judit Tóth, Rita Hirmondó

Förderung

  • National Office for Research and Technology, Hungary

Zitieren

APA

Molnár, D., Surányi, É. V., Gálik, N., Tóth, J., & Hirmondó, R. (2024). Assessing the Impact of Bedaquiline, Clofazimine, and Linezolid on Mycobacterial Genome Integrity. Biomolecules. https://doi.org/10.3390/biom14111451

Vancouver

Molnár D, Surányi ÉV, Gálik N, Tóth J, Hirmondó R. Assessing the Impact of Bedaquiline, Clofazimine, and Linezolid on Mycobacterial Genome Integrity. Biomolecules. 2024. doi:10.3390/biom14111451

BibTeX
@article{Molnr2024,
  author = {Molnár, Dániel and Surányi, Éva Viola and Gálik, Nikoletta and Tóth, Judit and Hirmondó, Rita},
  title = {Assessing the Impact of Bedaquiline, Clofazimine, and Linezolid on Mycobacterial Genome Integrity},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14111451}
}
Kostenlos starten →